Alex W. White

1.1k total citations
19 papers, 882 citations indexed

About

Alex W. White is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Alex W. White has authored 19 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Alex W. White's work include Cancer therapeutics and mechanisms (6 papers), Synthesis and biological activity (5 papers) and PARP inhibition in cancer therapy (5 papers). Alex W. White is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Synthesis and biological activity (5 papers) and PARP inhibition in cancer therapy (5 papers). Alex W. White collaborates with scholars based in United Kingdom, United States and Spain. Alex W. White's co-authors include Nicola J. Curtin, Zdeněk Hostomský, David R. Newell, A. Hilary Calvert, Bernard T. Golding, Roger J. Griffin, Karen A. Maegley, Andrew D. Westwell, Sheila Srinivasan and Robert J. Almassy and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Cancer and The Journal of Organic Chemistry.

In The Last Decade

Alex W. White

18 papers receiving 857 citations

Peers

Alex W. White

ONCOL

IMMUN

EEE

Donald J. Osterling United States

Ye Wu China

Sujeet Kumar India

Toshiki Murata Japan

Ateeq Ahmad India

Haizhen A. Zhong United States

Paul N. Sanderson United Kingdom

Judd Berman United States

E. K. RYU South Korea

Yongseok Choi South Korea

Donald J. Osterling United States

Alex W. White

514 ×1.2

462 ×1.2

ONCOL

232 ×0.8

71 ×0.9

IMMUN

108 ×1.6

EEE

Citations per year, relative to Alex W. White Alex W. White (= 1×) peers Donald J. Osterling

Countries citing papers authored by Alex W. White

Since Specialization

Citations

This map shows the geographic impact of Alex W. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex W. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex W. White more than expected).

Fields of papers citing papers by Alex W. White

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex W. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex W. White. The network helps show where Alex W. White may publish in the future.

Co-authorship network of co-authors of Alex W. White

This figure shows the co-authorship network connecting the top 25 collaborators of Alex W. White. A scholar is included among the top collaborators of Alex W. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex W. White. Alex W. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

White, Alex W., et al.. (2023). Effects of Tourniquet Features on Application Processes. Journal of Special Operations Medicine. 23(4). 11–11.

Owen, Lucy, Alex W. White, & Katie Laird. (2018). Characterisation and screening of antimicrobial essential oil components against clinically important antibiotic‐resistant bacteria using thin layer chromatography‐direct bioautography hyphenated with GC‐MS, LC‐MS and NMR. Phytochemical Analysis. 30(2). 121–131. 37 indexed citations

Lau, Wing Man, Charles M. Heard, & Alex W. White. (2013). Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis. Pharmaceutics. 5(2). 232–245. 7 indexed citations

White, Alex W., et al.. (2012). Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine. European Journal of Medicinal Chemistry. 56. 246–253. 36 indexed citations

Lau, Wing Man, Keng Wooi Ng, Alex W. White, & Charles M. Heard. (2011). Therapeutic and Cytotoxic Effects of the Novel Antipsoriasis Codrug, Naproxyl–Dithranol, on HaCaT Cells. Molecular Pharmaceutics. 8(6). 2398–2407. 14 indexed citations

Lau, Wing Man, Alex W. White, & Charles M. Heard. (2010). Topical Delivery of a Naproxen-Dithranol Co-drug: In Vitro Skin Penetration, Permeation, and Staining. Pharmaceutical Research. 27(12). 2734–2742. 19 indexed citations

White, Alex W., et al.. (2008). Protein–protein interactions as targets for small-molecule therapeutics in cancer. Expert Reviews in Molecular Medicine. 10. e8–e8. 84 indexed citations

Lau, Wing Man, et al.. (2008). Scope and Limitations of The Co-Drug Approach to Topical Drug Delivery. Current Pharmaceutical Design. 14(8). 794–802. 45 indexed citations

White, Alex W., Nicola J. Curtin, Brian Eastman, et al.. (2004). Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(10). 2433–2437. 60 indexed citations

10.

White, Alex W.. (2004). Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(10). 2433–2437. 1 indexed citations

11.

Rodríguez‐Pérez, Ana I., et al.. (2002). Effect of Cyclodextrins on the Solubility and Antimycotic Activity of Sertaconazole: Experimental and Computational Studies. Journal of Pharmaceutical Sciences. 91(11). 2408–2415. 15 indexed citations

12.

Delaney, Carol A., Suzanne Kyle, Alex W. White, et al.. (2000). Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines.. PubMed. 6(7). 2860–7. 164 indexed citations

13.

White, Alex W., Robert J. Almassy, A. Hilary Calvert, et al.. (2000). Resistance-Modifying Agents. 9. Synthesis and Biological Properties of Benzimidazole Inhibitors of the DNA Repair Enzyme Poly(ADP-ribose) Polymerase. Journal of Medicinal Chemistry. 43(22). 4084–4097. 253 indexed citations

14.

Bowman, Karen J., Alex W. White, B.T. Golding, Robert Griffin, & Nicola J. Curtin. (1998). Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064. British Journal of Cancer. 78(10). 1269–1277. 112 indexed citations

15.

White, Alex W., et al.. (1998). A novel demethylated oxygenated triterpenoid in crude oils from the Canadian Beaufort Sea and northeast Alaska. Tetrahedron Letters. 39(19). 3031–3034. 7 indexed citations

16.

Griffin, Roger J., Sheila Srinivasan, Alex W. White, et al.. (1996). Novel Benzimidazole and Quinazolinone Inhibitors of the DNA Repair Enzyme Poly(ADP‐ribose)polymerase*. Pharmacy and Pharmacology Communications. 2(1). 43–47. 9 indexed citations

17.

Davis, M. M. & Alex W. White. (1969). Synthesis of substituted 2,1-benzisothiazoles. The Journal of Organic Chemistry. 34(10). 2985–2988. 12 indexed citations

18.

Davis, M. M. & Alex W. White. (1969). Electrophilic subsitution in 2,1-benzisothiazoles. Journal of the Chemical Society C Organic. 2189–2189. 4 indexed citations

19.

White, Alex W., et al.. (1968). A simple synthesis of 2,1-benzisothiazole. Chemical Communications (London). 1547a–1547a. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact